Podoplanin and CD34 in peripheral nerve sheath tumours: focus on neurofibromatosis 1-associated atypical neurofibroma.
Patients suffering from neurofibromatosis type 1 and 2 (NF1 and NF2) are the main risk groups to develop peripheral nerve sheath tumours (PNSTs). In the present study, adhesion molecules CD34 and podoplanin were assessed in regard to their value for tumour classification and as indicators for tumour progression. A total of 103 NF1-, NF2- and schwannomatosis-associated neurofibromas, schwannomas and malignant peripheral nerve sheath tumours (MPNST), as well as 20 sporadic vestibular schwannomas and 9 control tissue samples, were labelled immunohistochemically for detection of podoplanin and CD34. CD34 was shown to be expressed in MPNST and all benign PNSTs except for the compact cellular parts of both, schwannomas and atypical neurofibromas. Podoplanin showed an inverse expression pattern to CD34 labelling mainly the compact parts of schwannoma and atypical neurofibroma. MPNSTs were characterized by strong podoplanin staining at the invasive front. NF1-patients who suffered from atypical neurofibromas did not develop MPNST at a higher frequency than other NF1-patients, although these tumours expressed podoplanin. Ki-67 proliferation indices did not differ significantly between neurofibromas, atypical neurofibromas and schwannomas. In accordance with other studies, CD34 was found to be of limited value for classification and grading of PNST due to its ubiquitous expression. Podoplanin expression in schwannoma and atypical neurofibroma adds to other phenotypic and genotypic similarities between these tumours, like nuclear atypia, regressive changes and euploid polyploidisation. Podoplanin expression in atypical neurofibroma was not associated with tumour progression towards MPNST.
Naber
Urs
U
Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Friedrich
Reinhard E
RE
Glatzel
Markus
M
Mautner
Victor Felix
VF
Hagel
Christian
C
D000328:Adult; D018952:Antigens, CD34 / Q000096:biosynthesis*; D014408:Biomarkers, Tumor / Q000032:analysis*; D018450:Disease Progression; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008562:Membrane Glycoproteins / Q000096:biosynthesis*; D018317:Nerve Sheath Neoplasms / Q000378:metabolism / Q000473:pathology; D009442:Neurilemmoma / Q000378:metabolism / Q000473:pathology; D009456:Neurofibromatosis 1 / Q000378:metabolism* / Q000473:pathology*; D000098853:Podoplanin
D018952:Antigens, CD34; D014408:Biomarkers, Tumor; D008562:Membrane Glycoproteins; C117468:PDPN protein, human; D000098853:Podoplanin
Cancer. 2007 Apr 1;109(7):1406-12
17330850
Blood. 2007 Aug 1;110(3):1076-7
17644746
Blood. 1990 Jun 15;75(12):2417-26
1693532
J Neurooncol. 2007 Apr;82(2):187-92
17111191
Immunity. 2005 Jan;22(1):43-57
15664158
Cell Stem Cell. 2007 Oct 11;1(4):443-57
18371380
Cell. 1990 Aug 10;62(3):599-608
2116237
Am J Clin Pathol. 2000 Jul;114(1):123-6
10884807
Anticancer Res. 2008 Sep-Oct;28(5B):2997-3006
19031946
Cell Oncol. 2004;26(5-6):335-45
15623944
Br J Dermatol. 2008 May;158(5):1008-12
18363759
J Cutan Pathol. 2009 Jan;36(1):89-102
19125742
Am J Surg Pathol. 1993 Oct;17(10):1039-45
7690524
Blood. 1990 May 15;75(10):1941-6
1692488
Int J Cancer. 2005 Mar 1;113(6):899-910
15515019
JAMA. 1997 Jul 2;278(1):51-7
9207339
J Exp Med. 1989 May 1;169(5):1721-31
2469766
Mod Pathol. 2005 Jan;18(1):105-10
15389250
J Cell Sci. 2008 Nov 15;121(Pt 22):3683-92
18987355
Anticancer Res. 2007 Jul-Aug;27(4A):1819-22
17649778
Neurology. 2005 Jun 14;64(11):1838-45
15955931
Cell. 1993 Mar 12;72(5):791-800
8453669
Clin Genet. 2008 Oct;74(4):358-66
18647326
Br J Cancer. 2007 Jan 15;96(1):1-5
17179989
Am J Clin Pathol. 2008 Jun;129(6):886-93
18480004
Virchows Arch. 2006 Aug;449(2):200-6
16736189
Br J Dermatol. 2005 Jul;153(1):79-82
16029330
Eur J Nucl Med Mol Imaging. 2006 Apr;33(4):428-32
16404595
Blood. 1995 Jan 1;85(1):96-105
7528578
J Clin Invest. 1988 Mar;81(3):951-5
2893812
J Med Genet. 2002 May;39(5):311-4
12011145
Blood. 1996 Jan 1;87(1):1-13
8547630
Mol Cell Biol. 2009 Mar;29(6):1472-86
19103750
Cancer Cell. 2006 Apr;9(4):261-72
16616332
Curr Opin Neurol. 2003 Feb;16(1):27-33
12544854
Childs Nerv Syst. 1999 Jul;15(6-7):295-308
10461778
Adv Anat Pathol. 2009 Jan;16(1):62-4
19098468
Arch Neurol. 1988 May;45(5):575-8
3128965